Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crackdown on persistent infections imminent

Lisa Melton

    The Lancet. Infectious Diseases
    |September 11, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toward actionable interventions in human aging (12th ARDD meeting, 2025).

    Aging·2026
    Same author

    Modelling synaptic dysfunction in childhood dementia using human iPSC-derived cortical networks.

    Nature communications·2026
    Same author

    Top ten news stories in 2025.

    Nature biotechnology·2025
    Same author

    Innovations in aging biology: highlights from the ARDD emerging science & technologies workshop.

    npj aging·2025
    Same author

    Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity.

    Aging·2024
    Same author

    Scientists hone tools to measure aging and rejuvenation interventions.

    Nature biotechnology·2023
    Same journal

    Nine-valent human papillomavirus vaccine: implications for cervical elimination.

    The Lancet. Infectious diseases·2026
    Same journal

    Community-engaged implementation strategies to increase doxycycline post-exposure prophylaxis uptake among men who have sex with men in China (DoxyForward): a three-group, open-label, randomised controlled trial.

    The Lancet. Infectious diseases·2026
    Same journal

    Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.

    The Lancet. Infectious diseases·2026
    Same journal

    Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

    The Lancet. Infectious diseases·2026
    Same journal

    Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study.

    The Lancet. Infectious diseases·2026
    Same journal

    Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?

    The Lancet. Infectious diseases·2026
    See all related articles